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The 230-kD bullous pemphigoid antigen (BPAG 1) , defined 
by autoantibodies in patient sera, is a hemidesmosomal 
p laque protein in tl:e same gene farr~ily as the intrac~llula r 
proteins desmoplak1l1 III.! and plectl11. "'! e h ad preVIOusly 
isolated, from a A.gt11 ltbrary , o verlappl11g eDNA clones 
with 6921 bp ofmRNA sequen ce for BPAG1. The coding 
sequ ence encoded by these clones included the 3' stop codon 
but not the 5' coding and non-coding region of the mRNA. 
To obtain these sequences we used the po lymerase chain 
reaction (peR) m ethod ca ll ed rapid amplifica tion of eDNA 
ends (RACE) . The PCR products were cloned into plasmids 
A utoantibod ies from patients with bullous pemphi goid define two distinct molecules found in hemidesmo-somes, a 230-kD plaque protein (termed BPAG1) and a 180-kD transmembrane protein (for a review see [1 D. 
Several groups, including ours, have recently cloned eDNA con-
taining codi ng sequence for human BPAG1 [2-4). These studies 
demonstrated that BPAG 1 belongs to a gene fami ly containing the 
intracellular proteins desmoplakin IIII (DP I/II) , molecules in the 
desmosome plaque, and plectin, an intermed iate filament binding 
protein [5). These conclusions were based on th e findin gs of homo 1-
ogous amino acid sequences in the amino and carboxy terminus and 
a coiled-coil a-helical rod structure in the center of these molecu les 
[3,5). Based on currently known coding sequence BPAG1 is proba-
bly an intracel lular protein. Although Sawamura et al [3), the only 
group to have reported a full-length coding region, have noted a 
computer pred iction for a transmembrane region in the carboxy 
terminus of the molecule, this prediction is very weak. In addition, 
immunoe lectron microscopic studies with antibodies directed 
against the carboxy terminus and central rod show an intracel lular 
location on the inner hemldesmosomal plaque [6), and homologies 
with DP Jill, which is an intracellular plaque protein , also suggest 
that BPAG 1 is intracellular. T herefore, based on known sequence, 
BPAG 1 is probably intracellular, at least at its carboxy terminus and 
rod domain. 
H owever, if BPAG1 is entirely intracel lular how can autoanti-
bod ies in patients cause disease? Because the carboxy termin us seems 
intracellul ar we speculated that perhaps there mi ght be an amino-
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and seque nced. With fiv e peR prime rs we w ere able to 
obtain overlapping clones containing the 5' region of the 
mRNA. An upstream stop codon in frame with the rest of the 
coding sequence demonstrates that the fu ll 5' coding se-
quence is obtained. Four different peR products from two 
separate reactions had the same 5' end, su ggesting that tl:is 5' 
end is n ear, o r at , the transcription start site. No alternatively 
spliced clones were found and no t ransmembran e site w~s 
predicted, confirming that BPAG 1 is an intrace llular heml-
desmosomal plaque prote in . K eywords: hemidesm osome, 
desmoplakin, adhesion.] l11Vest DerI'l1ato/1 01 :244 - 246, 1993 
terminal region with a tra nsmembrane region and a short extracel-
lular segment. W e, therefore, wanted to confirm the amino-ter-
minal sequence reported by Sawamura et ai, show an in-frame stop 
codon upstream of the first methionine to rul e out additional up-
stream sequence, and determine if alternatively spliced mRNAs 111 
the amino-terminal regio n were present. W e had previously cloned 
6921 bp of the 3' end of the BP AG 1 cDNA that incl uded the 3' stop 
codon. W e therefore cloned upstream cDNA sequence by a PCR 
technique called rapid amplification of cDNA ends (RACE) [7 ,8). 
U sing this technique we confirmed th e coding sequence, found an 
upstream stop codon, did not detect any alternatively spliced 5' 
sequences, and identified a probable transcription start site. 
MATERIALS AND METHODS 
mRNA was obtained, by the usc of poly-T sepharose spin columns (Pharma-
cia-LKB, Piscataway, NJ) , from human keratinocytes cultured in keratino-
cyte growth medium wi th 0.15 mM calcium (Clonctics, Palo Alto, CAl· 
cDNA was prepared from 0.5 Jig mRNA with primers complementary to 
known seguence and reverse transcriptase (Superscript, BRL, Bethesda, 
MD) . 
The RACE technigue was performed based on the procedure described by 
Frohman [7] . To remove deoxynucleotide triphosphates (dNTPs), fim-
strand cDNA was adjusted to 2 M ammonium acetate then precipited with 
2 X volume ethanol on dry icc. This precipitation was repeated, then the 
cDNA pell et was " tailed" at its 3' end with 1 pi 1 0 mM dATP (BRL) and 13 
units of termina l deoxytransferase (TdT, BRL) in a total volume of 30 III 
(TdT buffer, BRL) for 15 min at 37 · C. The single-stranded tailed cDNA 
was heated to 65·C for 15 min (to inactivate TdT), then diluted 1 : 500 with 
10 mM Tris-HCl, 1 mM ethylenediaminetetraacetic acid, pH 7.4. PCR was 
then carried out with a 3' gene specific primer (GSP) nested with respect to 
the reverse transcriptase primer. (The localization of these GSPs, named 
PI - P5, are show n in Figs 1 and 2). The 5' end of these GSPs contained 
additional bases to provide a convenient restriction site (Not I or Apa 1) for 
subseguent cloning. As a 5' primer the fo llowing base seguence was used: 
GTTGGATCCAAGCTTGTCGACT 17 • This primer contains BamHI, 
Hindlll, and Sail restriction sites at its 5' end . PCR was performed (Taq 
polymerase, buffers, and thermal cycler from Perkin-Elmer, Norwalk, CT) 
in 100 pI for 20 to 40 cycles with 25 pmol of the GSP, 2 pmol of the 
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Figure 1. Overlapping clones isolated by RACE. BPi, previously cloned 
BPAGl cDNA sequence; Pl - P5 show positions ofGSPs;BPfindicates final 
composite BPAG 1 cDNA sequence; bellt arrolV, position of the beginning of 
the coding region. Each PCR-cloned product has a IIII/1lber indicating a 
separate PCR experiment and a letter if more than one clone was obtained per 
experiment. Each x indicates a nucleotide that differs from the correspond-
ing region of an overlapping clone (see Fig 2 for exact nucleotides). 
5' primer, and 25 pmol of a primer (GTTGGATCCAAGCTTGTC-
GACTTT) representing the 5' end of the 5' primer (this decreases non-spe-
ci fic priming of the oligo-dT). The PCR an nealing temperature was ad-
justed for each primer to eliminate non-specific products (45 °C for PI and 
P2; 55 °C for P3; 60°C for P4 and P5). The extension and denaturation 
temperatures were 72 °C and 94°C, respectively. In some experiments a 
second round ofPCR was performed with a GSP nested upstream from the 
firs t GSP. The resultant PCR products were either size selected by isolation 
fro m agarose gels with diethylaminoethyl-cellulose paper (NA-45, 
Schleicher & Scheull , Keene, NH) or isolated from the primers with size-
frac tionation columns (ChromaSpin, Cion tech , Palo Alto, CAl. These PCR 
products were then digested with appropriate restriction enzymes, ligated 
into a similarly digested plasmid vector (pGEMIIZf-, Promega, Madison , 
W I), and used to transform DH5a cells (BRL). 
In some cases transformed DH5a cells were screened by plaque hybrid-
ization with oligonucleotide probes containing BPAGI sequence upstream 
of the gene-specific PCR primers and labeled at the 3' end (according to 
manufacturer's directions, ECL, Amersham, Arlington Heights, IL) . 
Clones were sequenced with double-stranded plasmid sequencing (Se-
quenase version 2.1, United States Biochemical, Cleveland , OH) in both 
directions. 
RESULTS AND DISCUSSION 
5' Extension cDNA Cloning of BPAGl with RACE Al-
though we used several methods for generating and isolating RACE 
products, we ultimately decided that the easiest method was to do 
one PCR reaction and then directly subclone the products into a 
plasmid vector. The bacterial colonies transformed with this liga-
tion reaction were then screened by colony hybridization with an 
ol igonucleotide of known BPAG 1 sequence. The positive clones 
w ith the largest cDNA inserts were then used for sequencing. 
Before RACE cloning we had cloned (in Agtll ) 6921 bp of 
BPAGl cDNA (Fig 1). By usi ng five GSPs we were able to clone 
overlapping fragments that represented th e full 5' end of the 
BPAG I mRNA (Fig 1). This amounted to another 1763 bp of se-
q uence. The overlap of these PCR clones indicates tbat they were 
derived from the same BPAG ImRNA, known to be 9 kb [9] . How-
ever, we confirmed by Northern blotting that PCRIA, the first 
PCR product, as well as the 100 bp at the most 5' end of the newly 
cloned BPAG 1 eDNA, hybridized to a 9-kb mRNA (data not 
shown). 
Sequence Analysis of the 5' Extension Clones Analysis of the 
sequence of the PCR clones revealed a long open reading frame 
starting with an ATG codon at base 103 and continuing in frame 
with previously obtained sequence for a total open reading frame 
encoding 2649 am ino acids with a predicted molecular wei ght of 
306,752 kD (Fig 2). The amino acid sequence predicted from the 
5' eDNA CLONING OF BPAGl 245 
coding region of these PCR clones is in entire agreement with that 
published by Sawamura et at [3]. No alternatively spliced clones 
were found . In addition we found 102 bp of 5' untranslated region 
that contained an in-fralne stop codon upstream of the initial ATG 
(Fig 2), showing that no further amino-terminal codin g sequence is 
present. 
Because PCR amplification may be subject to errors we compared 
the overlapping peR clones' nucl eotide sequences (Fig 1). Over-
lapping peR fragments had the same sequences with four excep-
tions (marked by xs in Fig 1, of wh ich the xs on PCR5B and PCR5C 
represent the same change; specific base changes are shown in Fig 
2) . The G at position 23 was present in PCR4 and PCR5A, and 
therefore was confirmed by PCR performed with two different 
primers. However, in PCRSB and PCR5C it was an A. This might 
be a PCR mistake or cou ld be allelic variation. Interes tingly, the 
other three changes noted were the third base of a coding triplet and 
did not change the encoded amino acid (see Fig 2) . These might be 
allelic variation. This speculation is further confi rmed because the T 
at position 246 was confirmed by PCR4, PC R5B, and PCRSC, and 
therefore is almost certain ly correct, but was a C in PCR5A. Because 
Sawamura et at [3] also found this to be a C it probably represents 
allel ic variation. 
Finally, clones PCR4, PCR5A, PCR5B, and PCR5C all ended 
with the same base just before the poly-T tail. This suggests that this 
first base is the beginning, or very close to the beginning, of the 
A 
GAGC TG CCACTTTTCACCGTTAGAAGTAGAGCTT TTT CCAGA 
4 3 CCTCCTACC T TTX~~TCTACTTTGAAAGGTGAAAGAAAGAACATCGTTTCAGGAATAAAA 
10 3 ATGCACAGTAGTAGTTATAGTTACCGTAGCAGTGATTCTGTGTTTAGTAACACTACCAGC 
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ACTCGAAC CAG TCT TGATTCAAA TG AAAATCTTCTCT1GG TT CATTGTGGTCCAACACTG 
TR TSLDSNENlLLVHC PTl 
C C 
ATCAACTCTTG CA T TAGCTTCGGTAGTGAA TCCTTTGATGGACACAGGTTAGAAA TGllG 
INSCI SFGSESFOGHAlEM L 
CAACAGAT TGCCAACAGAGTTCAGAGGGACAGTGTCATCTGTGAAGACAAACTGAlTeTT 
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CCCCTTCTAA AGTCTTCTTTGCTGGATCAAAATTTAACAGAAGAAGAAATCAATATGAAA 
P L L K S S L lP3 D 0 N L TEE E I N M K 
T ~ TG~ T C~GGS TC[ T T [GA~ T TW'"1Pf?1~.~8AC lGGSCC~CA¥TG~G 
TGGGGCT CAGA TTTG CCAAGTGTTGAAAGCCATTTAGAAAATCATAAAAATGTTCATAGA 
W SOLPSVESHlENHKNVHR 
GCTATTGAAG AA TTTGAA TCTAGTCTCAAAGAAGCTAAAATCAGTGAGATTCAAATGACA 
AIEEFESSLKEAKISEIOMT 
GCACC T CTTAAACTGACTTATGCAGAAAAGTTGCACAGATTAG~GAGTCAGTATGCAAAA 
APLKLTVAEKLHRLESOYAK 
1 183 CTCTTOAATACATCCAGGAATCAAGAACGGCACCTTGATACACTCCATAATTTTGTAAGT 
lLNT SR NO ERHLDTLHNFVS 
1 243 C~TG~GA~TA~TG~AC~lAITT~GT~GA~ T G~AA~AG~AG~GG~GG~AG~TG;TT¢TG~C 
1 3 0 3 T~GA~TG~GA~AA~CArCA~CAiAG~TA~GA~AA~AO~Tl~TC~TG~TG~AT~AA~GA~A 
1363 GAACTTGAT CAAAA GGAAGA AAA TATT AAA TCAGTTCAGGAGATAGCAGAGCAGCTAeTT 
ELOOKEENI KSVOE IAEOLL 
1 ~23 ClAG~AA~TC~TC~AGXCC~GTlAA9TAiTG:GG~CT¢CA~AG~GG~AA~GC~GA¥GC~G 
1~83 T~GA~CT~GAICTlAC~GC~CT~CC~G T ~TG~GG~GC~GC~CAIAA~GG~H~  
1 543 ~~GT~ TT~CA~ T G~TG;CA~AG~AG~TAfTG~TTeCT~AA~GA~ T ClAA~AGST 
160 3 GCCATTCAGCGGAAGTACAGCTGTGATAGATCAAGCAGCATTCACAAGCTAGAAGACCTT 
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GTTCAGGAATCAATGGAAGAGAAAGAAGAACTTCTGCAGTACAAAAGCACTA1AGCAAAC 
VOESMEEKEELLO,(KSTIAN 
CTAA TGGGA AAAGCAAAAACAATAA TT CAACTGAAGCc2AGOAATTCTGACTGTCCAC TC 
LMGKA KTIIOLKPRNSOCPL 
P 1 ... ... .... .• .. . 
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Figure 2. Nucleotide and amino acid sequence 0[5' BPAGl eDNA. Dotted 
box, in-frame upstream stop codon. Nucleotides on line above main nucleo-
tide sequence indicate base changes in some PCR clones. Reverse-higlrlighred 
bases indicate regions for wh ich complementary GSPs were made (with 
II/Imber of primer above and indicating 3' end of primer). Primers P4 and PI 
are indicated by dotted lilies instead of reverse highlights. Shaded nucleotides 
show previously known sequence. (Genbank accession number L11 690.) 
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transcription start site. If there were Ts just at the transcription start 
site we could not differentiate them from the tailed bases. However, 
transcription usually starts with a purine (A or G) [10] . In addition, 
the BPAG1 genomic DNA sequence (kindly provided by Tamai K 
et at [11]) indicates a putative transcription start site one base down-
stream of our predicted start site. Further studies, such as primer 
ex tension and S1 nuclease protection, would be necessary to exactly 
determine the transcription start site, if indeed it is limited to only 
one base. 
These results show the feasibility of using RACE for 5' extension 
cloning. The resultant clones indicate that the full cod ing sequence 
of BPAG 1 is obtained and there is not an amino-terminal trans-
membrane region. Therefore, like the related molecule DP li n, 
BPAG1 is an intracellular adhesion junction plaque protein. 
We tirallk Dr. Joseph Rot/mage! for his odilia 0 11 the /lse of the RACE procedllre. 
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